Currently, both the 5th edition of the World Health Organization (WHO) classification and the International Consensus Classification recognize two main MDS classes: MDS with defining genetic abnormalities (del(5q), SF3B1 and TP53 mutation) and morphologically defined MDS based on various cytological and histopathological features [1,2]. This evidence concerns the gene TP53 and myelodysplastic syndrome.